Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029

Global Diagnostic Radiopharmaceuticals Market Growth 2023-2029

Radiopharmaceuticals refer to a class of special medicines containing radionuclides for medical diagnosis and treatment. Compounds or biological preparations containing radionuclide labels used for medical diagnosis or treatment in the body. Diagnostic radiopharmaceuticals are radioisotopes that bind to biomolecules that can locate specific organs, tissues or cells in the body. These radiopharmaceuticals can be used to diagnose diseases.
LPI (LP Information)' newest research report, the “Diagnostic Radiopharmaceuticals Industry Forecast” looks at past sales and reviews total world Diagnostic Radiopharmaceuticals sales in 2022, providing a comprehensive analysis by region and market sector of projected Diagnostic Radiopharmaceuticals sales for 2023 through 2029. With Diagnostic Radiopharmaceuticals sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Diagnostic Radiopharmaceuticals industry.
This Insight Report provides a comprehensive analysis of the global Diagnostic Radiopharmaceuticals landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Radiopharmaceuticals portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Diagnostic Radiopharmaceuticals market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Diagnostic Radiopharmaceuticals and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Diagnostic Radiopharmaceuticals.
The global Diagnostic Radiopharmaceuticals market size is projected to grow from US$ 4289.7 million in 2022 to US$ 6959.8 million in 2029; it is expected to grow at a CAGR of 6959.8 from 2023 to 2029.
North America is the world's major consumer region, with sales accounting for 41.59% of the global total in 2019. Europe is also a major consumer region, accounting for 24.5% of the global market. China is also a very important consumer region due to the large number of cancers. At present, products represented by Cardinal Health, GE Healthcare, Curium Pharma, Jubilant Pharma, Bracco Imaging, etc. occupy a major position in the global market.
This report presents a comprehensive overview, market shares, and growth opportunities of Diagnostic Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Technetium 99
Fluorine 18
Other
Segmentation by application
Oncology
Cardiology
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Advanced Accelerator Applications
SIEMENS
China Isotope & Radiation
Dongcheng Pharmaceutical Group
Lantheus
Eli Lilly

Key Questions Addressed in this Report
What is the 10-year outlook for the global Diagnostic Radiopharmaceuticals market?
What factors are driving Diagnostic Radiopharmaceuticals market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Diagnostic Radiopharmaceuticals market opportunities vary by end market size?
How does Diagnostic Radiopharmaceuticals break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.